Duncan Low is a consultant providing technical services in raw materials management and risk management to both manufacturers and suppliers in the biopharmaceutical industry.
He is an active member of several industry groups and scientific advisory boards, including the ASTM, ISPE and PDA. His previous role as a Scientific Executive Director at Amgen (2003 – 2017), where he led the Raw Materials Global Network and Materials Science teams, provided broad insight to materials sourcing and change management. Prior to joining Amgen, he held VP positions at Millipore and Pharmacia Biotech. He has an M.A. in biochemistry from the University of Cambridge and a Ph.D. in microbiology from the University of Glasgow.